001044403 001__ 1044403
001044403 005__ 20260123203311.0
001044403 0247_ $$2doi$$a10.1016/j.omtn.2025.102616
001044403 0247_ $$2datacite_doi$$a10.34734/FZJ-2025-03167
001044403 037__ $$aFZJ-2025-03167
001044403 082__ $$a610
001044403 1001_ $$0P:(DE-HGF)0$$aZhang, Jiao$$b0
001044403 245__ $$aEffect of degeneration stage on non-viral tissue transfection of rd10 retina ex vivo
001044403 260__ $$aNew York, NY$$bNature Publ. Group$$c2025
001044403 3367_ $$2DRIVER$$aarticle
001044403 3367_ $$2DataCite$$aOutput Types/Journal article
001044403 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1769162618_14858
001044403 3367_ $$2BibTeX$$aARTICLE
001044403 3367_ $$2ORCID$$aJOURNAL_ARTICLE
001044403 3367_ $$00$$2EndNote$$aJournal Article
001044403 500__ $$aThis work was supported by the Confocal Microscope Facility and the Immunohistochemistry Facility, core facilities of the Interdisciplinary Center for Clinical Research (IZKF) Aachen within the Faculty of Medicine at RWTH Aachen University. Thethors thank Anne Freialdenhoven, Antje Schiefer, and Alicia Hühnlein (Department of Ophthalmology, University Hospital RWTH Aachen) for excellent technicaltance. This work was funded by the China Scholarship Council (no. 202208080251) and is part of a graduate school funded by the Deutsche Forschungsgemeinschaft DFG under GRK 2610/01. The results shown here are part of the doctoral thesis of J.Z.
001044403 520__ $$aGene therapy has great potential for the treatment of inherited retinal diseases, as evidenced by the progress and ongoing research. Using the Sleeping Beauty (SB) transposon system, we developed a non-viral gene delivery system for electroporation-based transfection of rd10 retinas ex vivo. SB100X transposase and Venus transposon plasmids were transfected at a ratio of 1:16 into rd10 retinas of different ages and corresponding wild-type (WT) controls. Transfection efficiency was assessed by fluorescence microscopy and transfected cells were identified by immunohistochemistry. Retinal integrity and cell viability were assessed by FITC-dextran electroporation, histology, and apoptosis assay. The highest transfection efficiency was observed in degenerated stages P61 and older, with Müller cells being the only transfected cell type. A 31% reduction in transposon plasmid size resulted in a 1.5-fold increase in transfection efficiency. Integrity and morphology of degenerated retinas were preserved after electroporation-based plasmid transfer; the number of apoptotic cells in the inner nuclear layer (INL) was reduced by half compared to WT controls. We demonstrated that electroporation-based delivery of the SB transposon system resulted in efficient transfection of degenerated retinas. Our results are an important first step toward the combined use of retinal prostheses and gene therapy to improve the treatment of inherited retinal dystrophies.
001044403 536__ $$0G:(DE-HGF)POF4-5244$$a5244 - Information Processing in Neuronal Networks (POF4-524)$$cPOF4-524$$fPOF IV$$x0
001044403 536__ $$0G:(GEPRIS)424556709$$aGRK 2610 - GRK 2610: Innovative Schnittstellen zur Retina für optimiertes künstliches Sehen - InnoRetVision (424556709)$$c424556709$$x1
001044403 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
001044403 7001_ $$0P:(DE-HGF)0$$aBing, Ziyu$$b1
001044403 7001_ $$0P:(DE-HGF)0$$aMarie, Corinne$$b2
001044403 7001_ $$0P:(DE-HGF)0$$aIzsvák, Zsuzsanna$$b3
001044403 7001_ $$0P:(DE-Juel1)131939$$aMüller, Frank$$b4
001044403 7001_ $$0P:(DE-HGF)0$$aThumann, Gabriele$$b5
001044403 7001_ $$0P:(DE-Juel1)209653$$aWalter, Peter$$b6$$ufzj
001044403 7001_ $$0P:(DE-HGF)0$$aJohnen, Sandra$$b7$$eCorresponding author
001044403 773__ $$0PERI:(DE-600)2662631-7$$a10.1016/j.omtn.2025.102616$$gVol. 36, no. 3, p. 102616 -$$n3$$p102616 -$$tMolecular therapy / Nucleic Acids$$v36$$x2162-2531$$y2025
001044403 8564_ $$uhttps://juser.fz-juelich.de/record/1044403/files/Molecular_Therapy_M%C3%BCller_06_2025.pdf$$yOpenAccess
001044403 909CO $$ooai:juser.fz-juelich.de:1044403$$popenaire$$popen_access$$pVDB$$pdriver$$pdnbdelivery
001044403 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131939$$aForschungszentrum Jülich$$b4$$kFZJ
001044403 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)209653$$aForschungszentrum Jülich$$b6$$kFZJ
001044403 9131_ $$0G:(DE-HGF)POF4-524$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5244$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vMolecular and Cellular Information Processing$$x0
001044403 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-05
001044403 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-05
001044403 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-12-05
001044403 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2024-12-05
001044403 915__ $$0LIC:(DE-HGF)CCBYNCND4$$2HGFVOC$$aCreative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
001044403 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bMOL THER-NUCL ACIDS : 2022$$d2024-12-05
001044403 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2023-05-02T08:49:38Z
001044403 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2023-05-02T08:49:38Z
001044403 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-05
001044403 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2024-12-05
001044403 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-05
001044403 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
001044403 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2023-05-02T08:49:38Z
001044403 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2024-12-05
001044403 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bMOL THER-NUCL ACIDS : 2022$$d2024-12-05
001044403 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-05
001044403 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-05
001044403 920__ $$lyes
001044403 9201_ $$0I:(DE-Juel1)IBI-1-20200312$$kIBI-1$$lMolekular- und Zellphysiologie$$x0
001044403 9201_ $$0I:(DE-Juel1)INW-1-20231219$$kINW-1$$lKatalytische Grenzflächen$$x1
001044403 980__ $$ajournal
001044403 980__ $$aVDB
001044403 980__ $$aUNRESTRICTED
001044403 980__ $$aI:(DE-Juel1)IBI-1-20200312
001044403 980__ $$aI:(DE-Juel1)INW-1-20231219
001044403 9801_ $$aFullTexts